• No results found

FLT3-ITD

An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemia

An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemia

... The pMIG plasmid containing human FLT3- ITD was previously described [34]. For retrovirus production, 6 µg pMIG-FLT3-ITD or empty vector were transfected into Phoenix E cells using ...

11

Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia

Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia

... in FLT3-ITD expressing MV4-11 cells significantly inhibited the directed trans-well migration towards FCS which contains lysophosphatidic acid (LPA) as a major ...in FLT3- ITD positive ...

12

Chronic FLT3 ITD signaling in acute myeloid leukemia is connected to a specific chromatin signature

Chronic FLT3 ITD signaling in acute myeloid leukemia is connected to a specific chromatin signature

... mutated FLT3 growth factor receptor to the nucleus and demon- strates a profound impact of aberrant signaling on transcription factor binding and FLT3-ITD-specific gene ...aberrant ...

18

Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature

Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature

... the FLT3 transmembrane domain as a paradigm. FLT3-ITD mutations are found in 25% of KN-AML and lead to constitutive activation of the downstream mitogen-activated protein kinase (MAPK), AKT, and ...

17

FLT3-ITD Negative Refractory/Relapsed or Geratic AML Patients Responded Well to Salvage Treatment with Low Dose Cytarabine and Sorafenib

FLT3-ITD Negative Refractory/Relapsed or Geratic AML Patients Responded Well to Salvage Treatment with Low Dose Cytarabine and Sorafenib

... As a primary study on sorafenib treatment of AML patients without FLT3-ITD mutation, there are obvious shortcomings in this report. First, the relationship of c-Kit mutation and sorafenib responses in our ...

6

Dnmt3a deletion cooperates with the Flt3/ITD mutation to drive leukemogenesis in a murine model

Dnmt3a deletion cooperates with the Flt3/ITD mutation to drive leukemogenesis in a murine model

... After determining that Dnmt3a loss and the Flt3/ ITD mutation do indeed cooperate to greatly expand the LT-HSC pool, we sought to investigate the mechanism underlying this observation. To assess ...

12

Long Noncoding RNA SOCS2-AS Promotes Leukemogenesis in FLT3-ITD+ Acute Myeloid Leukemia Through miRNA-221

<p>Long Noncoding RNA SOCS2-AS Promotes Leukemogenesis in FLT3-ITD+ Acute Myeloid Leukemia Through miRNA-221</p>

... Acute myeloid leukemia (AML) is a malignant hematological disease caused by uncontrolled proliferation, blocked apoptosis and dysdifferentiation of bone marrow hematopoietic stem cells. 1 The mutation of FMS-like ...

10

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia

... type FLT3, upon different culture conditions, including stimulation by GM-CSF, IL-3 or G-CSF (Supplementary Figure ...in FLT3-ITD positive cell lines (Supplementary Figure S2c and S2d), suggesting ...

18

FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia

FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia

... expressing FLT3-ITD, in accordance with a previous report ...expressing FLT3-ITD, ...by FLT3-ITD may play a role in acquisition of the resistance to the PI3K/Akt pathway ...

17

Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia

Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia

... wild-type FLT3-ITD (p = ...and FLT3- ITD positive AML in the univariate analysis, however, they were not found to be independently significant in multivariate ...type FLT3-ITD ...

14

Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression

Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression

... with FLT3 ITD had the highest DUSP6 protein ex- pression, however, wildtype FLT3 expressing cells also showed increased DUSP6 protein levels when compared to parental 32D cells, possibly caused by ...

15

Profile of Quizartinib for the Treatment of Adult Patients with Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date

<p>Profile of Quizartinib for the Treatment of Adult Patients with Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date</p>

... the FLT3 kinase ...to FLT3 relies on edge-to-face aromatic interac- tions mediated by the gatekeeper residue, F691, and activation loop ...the FLT3-quizartinib complex further suggests that once the ...

13

Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones

Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones

... of FLT3/ITD mutations at ...the FLT3/ITD mutations are present only in subclones derived from the original LSC, subclones that lack the capacity for ...Alternately, FLT3 mutations could ...

12

Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients

Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients

... increase FLT3 ITD detection sensitivity of the routine RT-PCR assay ...were FLT3 ITD- at diagnosis and relapsed as FLT3 ITD+, actually had a small original FLT3 ...

11

Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modification

Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modification

... ROS might function as a double-edged sword. Previous reports have demonstrated that adequate amount of ROS is essential for regulation of physiological event, while excessive production could lead to cell death [27, 30, ...

12

Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress

Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress

... in FLT3-ITD AML is complex. FLT3-ITD cells have high baseline ROS levels [50] which are associated with increased DNA ...in FLT3-ITD cells also inactivate the protein tyrosine ...

16

T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3 -ITD mutated acute myeloid leukemia

T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3 -ITD mutated acute myeloid leukemia

... in FLT3-ITD mutated AML cells in comparison to FLT3-wt AML cells, we performed gene expression microarray analysis in FLT3-ITD mutated MV4-11 cells transfected with TOPK-siRNA or ...

16

Arsenic trioxide potentiates Gilteritinib-induced apoptosis in FLT3-ITD positive leukemic cells via IRE1a-JNK-mediated endoplasmic reticulum stress

Arsenic trioxide potentiates Gilteritinib-induced apoptosis in FLT3-ITD positive leukemic cells via IRE1a-JNK-mediated endoplasmic reticulum stress

... of FLT3 TKIs like Crenolanib and ...on FLT3-ITD/D835Y mutation than Quizartinib [38] and the therapeutic effect of Crenolanib at the maxi- mum tolerable dose is limited compared to Gilteritinib in ...

14

Frequency of FLT3 ITD and FLT3 TKD Mutations in Multiple Myeloma Patients (A Case Control Study)

Frequency of FLT3 ITD and FLT3 TKD Mutations in Multiple Myeloma Patients (A Case Control Study)

... no FLT3 mutation either TKD or ITD was found in the study ...14.4% ITD and 4.1 %TKD [21]; ALL, 1.3% ITD and ...3.4% ITD and 1.14%TKD [23]; and MDS, 0.71% ITD and ...

7

Emerging therapies for acute myeloid leukemia: translating biology into the clinic

Emerging therapies for acute myeloid leukemia: translating biology into the clinic

... the FLT3 receptor tyrosine ...AML, FLT3 and its inhibitors are most advanced. FLT3 encodes a receptor tyrosine kinase containing a characteristic interrupted kinase domain ...1). FLT3 is ...

16

Show all 142 documents...

Related subjects